Kanamycin Susceptibility Testing of Mycobacterium tuberculosis Using Mycobacterium Growth Indicator Tube and a Colorimetric Method
- 1 June 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (6), 1934-6
- https://doi.org/10.1128/aac.45.6.1934-1936.2001
Abstract
Two novel systems were evaluated for performing indirect kanamycin susceptibility tests on 72 strains of Mycobacterium tuberculosis . The microplate Alamar blue colorimetric method (breakpoint, 2.5 μg/ml) and the Mycobacterium Growth Indicator Tube (MGIT) system (breakpoint, 5.0 μg/ml) both produced 98.6% agreement when compared with the conventional proportion method performed on 7H10 agar using 5.0 μg of kanamycin/ml. Both systems provided results within an average of 1 week.Keywords
This publication has 17 references indexed in Scilit:
- Evaluation of Mycobacteria Growth Indicator Tube for Direct and Indirect Drug Susceptibility Testing of Mycobacterium tuberculosis from Respiratory Specimens in a Siberian Prison HospitalJournal of Clinical Microbiology, 2001
- Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.Published by Wiley ,2000
- Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?2000
- Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosisPublished by Springer Nature ,2000
- Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997New England Journal of Medicine, 1998
- Tuberculosis in siberia: 2. Diagnosis, chemoprophylaxis and treatmentTubercle and Lung Disease, 1996
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosisAntimicrobial Agents and Chemotherapy, 1989
- MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugsAntimicrobial Agents and Chemotherapy, 1988
- Amikacin in the treatment of pulmonary tuberculosisTubercle, 1983